Ankit Shrivastava

Title: Ankit Shrivastava: Innovator in Pharmaceutical Formulations

Introduction

Ankit Shrivastava is a notable inventor based in Madhya Pradesh, India. He has made significant contributions to the field of pharmaceutical formulations, particularly focusing on improving the pharmacokinetic profile of medications. His innovative approach has the potential to enhance therapeutic outcomes for patients.

Latest Patents

Ankit holds a patent for a novel pharmaceutical formulation. His patent, titled "Pharmaceutical formulations," describes how the pharmacokinetic profile of the SGLT2 inhibitor bexagliflozin can be improved by formulating it as an extended-release tablet. This formulation allows for a lower peak plasma concentration while maintaining therapeutic levels for an extended period. This advancement can enable the administration of lower doses without compromising the pharmacological effect.

Career Highlights

Ankit is currently associated with Theracosbio, LLC, where he continues to work on innovative pharmaceutical solutions. His expertise in drug formulation and delivery systems has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Ankit collaborates with talented professionals in his field, including Feng Wang and Rina Shah. Their combined efforts contribute to the advancement of pharmaceutical research and development.

Conclusion

Ankit Shrivastava's work in pharmaceutical formulations exemplifies the impact of innovation in healthcare. His contributions are paving the way for more effective medication delivery systems, ultimately benefiting patients worldwide.